
STS NATIONAL CARDIAC SURGERY DATABASE
1996 MITRAL VALVE REPLACEMENT PATIENTS
UNIVARIATE ANALYSIS: PREOPERATIVE RISK VARIABLES
PATIENT POPULATION: 4,151
RISK VARIABLE | Count | % of Pop. | Mortality w/ Variable Present | Mortality w/ Variable Absent | Relative Risk | c 2 p-Value | ||
Male | 1,612 | 38.83% | 69/ 1,612 | 4.28% | 153/ 2,539 | 6.03% | 0.71 | 0.0148 |
Female | 2,539 | 61.17% | 153/ 2,539 | 6.03% | 69/ 1,612 | 4.28% | 1.41 | 0.0148 |
Caucasian | 3,394 | 81.76% | 176/ 3,394 | 5.19% | 46/ 757 | 6.08% | 0.85 | 0.3245 |
Non-Caucasian | 757 | 18.24% | 46/ 757 | 6.08% | 176/ 3,394 | 5.19% | 1.17 | 0.3245 |
Smoking History | 1,651 | 39.77% | 76/ 1,651 | 4.60% | 146/ 2,500 | 5.84% | 0.79 | 0.0830 |
Family History | 957 | 23.05% | 40/ 957 | 4.18% | 182/ 3,194 | 5.70% | 0.73 | 0.0670 |
Diabetes | 450 | 10.84% | 42/ 450 | 9.33% | 180/ 3,701 | 4.86% | 1.92 | 0.0001 |
Morbid Obesity | 287 | 6.91% | 19/ 287 | 6.62% | 203/ 3,864 | 5.25% | 1.26 | 0.3208 |
Hypercholesterolemia | 873 | 21.03% | 42/ 873 | 4.81% | 180/ 3,278 | 5.49% | 0.88 | 0.4273 |
Renal Failure | 250 | 6.02% | 46/ 250 | 18.40% | 176/ 3,901 | 4.51% | 4.08 | 0.0000 |
Renal Failure Requiring Dialysis | 70 | 1.69% | 17/ 70 | 24.29% | 205/ 4,081 | 5.02% | 4.83 | 0.0000 |
Hypertension | 1,580 | 38.06% | 108/ 1,580 | 6.84% | 114/ 2,571 | 4.43% | 1.54 | 0.0008 |
Pulmonary Hypertension | 1,451 | 34.96% | 97/ 1,451 | 6.69% | 125/ 2,700 | 4.63% | 1.44 | 0.0050 |
CVA | 404 | 9.73% | 24/ 404 | 5.94% | 198/ 3,747 | 5.28% | 1.12 | 0.5775 |
Endocarditis | 407 | 9.80% | 35/ 407 | 8.60% | 187/ 3,744 | 4.99% | 1.72 | 0.0021 |
Cardiomegaly | 1,084 | 26.11% | 52/ 1,084 | 4.80% | 170/ 3,067 | 5.54% | 0.87 | 0.3482 |
COPD | 637 | 15.35% | 42/ 637 | 6.59% | 180/ 3,514 | 5.12% | 1.29 | 0.1289 |
Immunosuppressive Rx | 80 | 1.93% | 8/ 80 | 10.00% | 214/ 4,071 | 5.26% | 1.90 | 0.0618 |
Peripheral Vascular Disease | 24 | 0.58% | 3/ 24 | 12.50% | 219/ 4,127 | 5.31% | 2.36 | 0.1183 |
Cerebrovascular Disease | 309 | 7.44% | 20/ 309 | 6.47% | 202/ 3,842 | 5.26% | 1.23 | 0.3612 |
Prior CAB | 293 | 7.06% | 38/ 293 | 12.97% | 184/ 3,858 | 4.77% | 2.72 | 0.0000 |
Prior Valve | 905 | 21.80% | 62/ 905 | 6.85% | 160/ 3,246 | 4.93% | 1.39 | 0.0231 |
Prior Other Cardiac | 245 | 5.90% | 27/ 245 | 11.02% | 195/ 3,906 | 4.99% | 2.21 | 0.0000 |
Prior Non-Cardiac | 133 | 3.20% | 8/ 133 | 6.02% | 214/ 4,018 | 5.33% | 1.13 | 0.7282 |
Prior Non-Surgical | 208 | 5.01% | 10/ 208 | 4.81% | 212/ 3,943 | 5.38% | 0.89 | 0.7223 |
PTCA To OR <6Hrs | 2 | 0.05% | 1/ 2 | 50.00% | 221/ 4,149 | 5.33% | 9.39 | 0.0050 |
PTCA To OR >6Hrs | 49 | 1.18% | 5/ 49 | 10.20% | 217/ 4,102 | 5.29% | 1.93 | 0.1286 |
Pior MI <6 Hrs vs. No MI | 6 | 0.14% | 0/ 6 | 0.00% | 178/ 3,836 | 4.64% | 0.00 | 0.5890 |
Prior MI 6 to 24 Hrs vs. No MI | 3 | 0.07% | 2/ 3 | 66.67% | 178/ 3,836 | 4.64% | 14.37 | 0.0000 |
Prior MI 1-7 Days vs. No MI | 39 | 0.94% | 15/ 39 | 38.46% | 178/ 3,836 | 4.64% | 8.29 | 0.0000 |
Prior MI 7-21 Days vs. No MI | 30 | 0.72% | 9/ 30 | 30.00% | 178/ 3,836 | 4.64% | 6.47 | 0.0000 |
Prior MI >21 Days vs. No MI | 237 | 5.71% | 18/ 237 | 7.59% | 178/ 3,836 | 4.64% | 1.64 | 0.0392 |
Congestive Heart Failure | 2,513 | 60.54% | 160/ 2,513 | 6.37% | 62/ 1,638 | 3.79% | 1.68 | 0.0003 |
Unstable Angina | 230 | 5.54% | 32/ 230 | 13.91% | 190/ 3,921 | 4.85% | 2.87 | 0.0000 |
Cardiogenic Shock | 128 | 3.08% | 32/ 128 | 25.00% | 190/ 4,023 | 4.72% | 5.29 | 0.0000 |
Resuscitation | 45 | 1.08% | 10/ 45 | 22.22% | 212/ 4,106 | 5.16% | 4.30 | 0.0000 |
Arrhythmia | 2,008 | 48.37% | 108/ 2,008 | 5.38% | 114/ 2,143 | 5.32% | 1.01 | 0.9329 |
Digitalis | 2,061 | 49.65% | 104/ 2,061 | 5.05% | 118/ 2,090 | 5.65% | 0.89 | 0.3904 |
Beta Blockers | 722 | 17.39% | 33/ 722 | 4.57% | 189/ 3,429 | 5.51% | 0.83 | 0.3070 |
Ca Antagonists | 757 | 18.24% | 43/ 757 | 5.68% | 179/ 3,394 | 5.27% | 1.08 | 0.6532 |
ACE Inhibitors | 1,415 | 34.09% | 75/ 1,415 | 5.30% | 147/ 2,736 | 5.37% | 0.99 | 0.9217 |
Nitrates - P.O. | 391 | 9.42% | 27/ 391 | 6.91% | 195/ 3,760 | 5.19% | 1.33 | 0.1504 |
Nitrates - I.V. | 144 | 3.47% | 21/ 144 | 14.58% | 201/ 4,007 | 5.02% | 2.91 | 0.0000 |
Antiarrhythmics | 464 | 11.18% | 34/ 464 | 7.33% | 188/ 3,687 | 5.10% | 1.44 | 0.0443 |
Antiplatelets | 627 | 15.10% | 43/ 627 | 6.86% | 179/ 3,524 | 5.08% | 1.35 | 0.0682 |
Anticoagulants | 1,601 | 38.57% | 99/ 1,601 | 6.18% | 123/ 2,550 | 4.82% | 1.28 | 0.0580 |
Diuretics | 2,289 | 55.14% | 146/ 2,289 | 6.38% | 76/ 1,862 | 4.08% | 1.56 | 0.0011 |
Inotropes | 197 | 4.75% | 35/ 197 | 17.77% | 187/ 3,954 | 4.73% | 3.76 | 0.0000 |
Steroids | 155 | 3.73% | 14/ 155 | 9.03% | 208/ 3,996 | 5.21% | 1.74 | 0.0377 |
Aspirin | 820 | 19.75% | 56/ 820 | 6.83% | 166/ 3,331 | 4.98% | 1.37 | 0.0353 |